Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
6 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.
11 Jan 2020
Prevention of glucocorticoid-induced osteoporosis (GIOP) and postmenopausal osteoporosis (PMOP) remains inadequate in patients with rheumatoid arthritis (RA), as shown in a study that evaluated the implementation of the 2003 and 2014 French guidelines on the prevention and treatment of GIOP and the 2012 update of the French guidelines for the treatment of PMOP.

Healthier diets delay unhealthy ageing

16 Oct 2019

Better-quality diets facilitate healthy ageing, slowing down the accumulation of deficits, particularly functional deterioration, a recent study has found.

Using the Mediterranean Diet Adherence Screener (MEDAS), Mediterranean Diet Score (MDS) and the Alternate Healthy Eating Index-2010 (AHEI-2010), researchers assessed diet quality in 2,042 ageing individuals (aged 60 years; 1,058 females). Ageing quality was measured using a 52-item health deficit accumulation index. Evaluations were performed over three waves.

Diet quality scores improved from baseline (wave 0) to wave 1 (MEDAS: mean change, 0.31, 95 percent CI, 0.22–0.40; MDS: mean change, 0.04, –0.04 to 0.14; AHEI-2010: mean change, 1.38, 0.90–1.87).

These improvements corresponded to subsequent changes in deficit accumulation over time. Those who showed little or no change in MEDAS scores, for instance, accumulated significantly less deficits from wave 0 to wave 2 relative to those with >1-point score decreases (β, –1.13, –2.20 to –0.07). This was also true for those who had >1-point increases (β, –1.49, –2.88 to –0.10; p-trend=0.04).

A one-standard deviation (SD) increase in MDS scores from wave 0 to wave 1 likewise led to significantly lower deficit accumulation from wave 0 to wave 2 (β, –0.72, –1.20 to –0.25) compared to those whose scores dropped by >1 SD.

A similar change in AHEI-2010 scores from wave 0 to wave 1 also corresponded to a significant decrease in deficit accumulation over the same time span (β, –0.57, –0.83 to –0.21) and the entire follow-up period (β, –0.67, –1.13 to –0.21).

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
6 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.
11 Jan 2020
Prevention of glucocorticoid-induced osteoporosis (GIOP) and postmenopausal osteoporosis (PMOP) remains inadequate in patients with rheumatoid arthritis (RA), as shown in a study that evaluated the implementation of the 2003 and 2014 French guidelines on the prevention and treatment of GIOP and the 2012 update of the French guidelines for the treatment of PMOP.